Apreo Health has filed a notice of an exempt offering of securities to raise $130,631,884.00 in New Funding.
According to filings with the U.S. Securities and Exchange Commission, Apreo Health is raising up to $130,631,884.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.
About Apreo Health
Apreo Health is an emerging clinical-stage medical device company dedicated to restoring health and quality of life to patients afflicted with severe emphysema, an advanced form of Chronic Obstructive Pulmonary Disease (COPD). In 2018 COPD was the second leading cause of death in United States of America(1) behind Ischemic Heart Disease, with over 8,000 deaths due to emphysema in 2023(2). Apreo Healths first product, the Apreo BREATHE Airway Scaffold is a novel implant designed to gently release air trapped in affected hyper-inflated lungs. Apreo Health is dedicated to pioneering safe, transformative solutions for lung disease. We serve patients with passion, integrity and a commitment to restoring their health and quality of life. Apreo is a privately held company headquartered in Menlo Park, CA., USA.
To learn more about Apreo Health, visit https://apreohealth.com/
Apreo Health Linkedin Page: https://www.linkedin.com/company/apreo-health/
Contact:
Karun Naga, Chief Executive Officer
310-709-1818
https://www.linkedin.com/in/karunnaga/
SOURCE: http://www.intelligence360.io
Copyright (c) 2025 SI360 Inc. All rights reserved.
